However, recently, letrozole, a nonsteroidal aromatase inhibitor that elicits more significant and comprehensive phenotypes of PCOS, has been regarded as a better PCOS inducer than other agents [21,22]. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.